Medicine and Dentistry
Patient
100%
Psoriasis
62%
Therapeutic Procedure
51%
Combination Therapy
22%
Diseases
19%
Inpatient
14%
Psoriasis Vulgaris
14%
Psoriatic Arthritis
13%
Skin
12%
Drug
10%
Tumor Necrosis Factor
10%
Chemotherapeutic Agent
10%
Bullous Pemphigoid
10%
Tumor Necrosis Factor
9%
Biological Product
9%
Transplantation
9%
Hidradenitis Suppurativa
8%
Inflammatory Bowel Disease
8%
Prevalence
8%
Atopic Dermatitis
8%
Dermatosis
7%
Skin Defect
7%
Adverse Event
7%
Systemic Therapy
7%
Erythema Nodosum
7%
Diagnosis
7%
Woman
7%
Dupilumab
7%
Case Report
7%
Age
7%
Experience
6%
Lesion
6%
Pyoderma gangrenosum
6%
Quality of Life
6%
Toxic Epidermal Necrolysis
6%
TNF Inhibitor
6%
Association
6%
Erythema Multiforme
5%
Psoriasis Area and Severity Index
5%
Life
5%
Immunosuppressive Treatment
5%
Risankizumab
5%
Cytokine
5%
Consensus
5%
Infliximab
5%
Serositis
5%
Development
5%
Nursing and Health Professions
Patient
26%
Psoriasis
25%
Inpatient
12%
Psoriasis Vulgaris
7%
Biological Product
6%
Psoriatic Arthritis
6%
Psoriasis Area and Severity Index
6%
Ixekizumab
6%
Etanercept
5%
Drug
5%
Pharmacology, Toxicology and Pharmaceutical Science
Psoriasis
36%
Drug
7%
Psoriasis Vulgaris
6%
Etanercept
6%
Biological Product
6%
Diseases
6%
Adverse Event
5%
Prevalence
5%
Tumor Necrosis Factor
5%
Atopic Dermatitis
5%
